FDA approves Johns Hopkins University plasma therapy trial
Johns Hopkins University Bloomberg School of Public Health’s Dr. Arturo Casadevall on efforts to treat COVID-19 with blood plasma.
FDA approves Johns Hopkins University plasma therapy trial
Johns Hopkins University Bloomberg School of Public Health’s Dr. Arturo Casadevall on efforts to treat COVID-19 with blood plasma.